An accomplished healthcare executive, Prakash brings over 25 years of experience in biopharma, capital markets, and entrepreneurship. His track record spans private and public companies, startups and large corporations, and different business models, healthcare verticals and emerging sectors. As a leader and strategist, he has held responsibility for people, P&Ls, financing, licensing, M&A, and go-public leadership.
Prakash is currently Vice President at TIAP, a not-for-profit organization that identifies, funds, and accelerates transformative, member-sourced, early-stage medical innovation into successful Canadian companies.
Before joining TIAP, he was Chief Operating Officer and Head of Corporate Development at a mental health and psychedelic medicine company where he played pivotal roles in building a network of clinics, bringing the company public, optimizing value of the U.S. operations, executing acquisitions, and managing the sale of the business. Previously, as Co-founder of a genetic testing company in medical cannabis, he worked collaboratively to assemble the team, develop and market the test, and eventually sell the company.
Prakash is also a seasoned capital markets professional, having served in senior biotech equity research and investment banking roles at CIBC World Markets, National Bank Financial, and Canaccord Capital. The foundation of his career was built in commercial operations and new product development in the pharmaceutical industry.
Mr. Gowd serves as a board director of HDAX Therapeutics and Appili Therapeutics, and previously served as director at FendX Technologies and at Isotechnika Pharma, the predecessor company to Aurinia Pharmaceuticals. He holds an MBA from McGill University, a Pharmacy degree from the University of British Columbia, and a Chartered Director designation.
